

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sensory perception of smell (GO:0007608) | 6.62763234 |
| 2 | behavioral response to nicotine (GO:0035095) | 6.47197008 |
| 3 | sulfation (GO:0051923) | 5.15441296 |
| 4 | * cell proliferation in forebrain (GO:0021846) | 4.78468954 |
| 5 | axonal fasciculation (GO:0007413) | 4.42483390 |
| 6 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.36771665 |
| 7 | somite development (GO:0061053) | 4.09664409 |
| 8 | neuron recognition (GO:0008038) | 4.09115159 |
| 9 | regulation of glomerulus development (GO:0090192) | 4.04500596 |
| 10 | spinal cord development (GO:0021510) | 3.98426398 |
| 11 | olfactory bulb development (GO:0021772) | 3.98205710 |
| 12 | sensory perception of chemical stimulus (GO:0007606) | 3.97177198 |
| 13 | metanephric tubule development (GO:0072170) | 3.97092804 |
| 14 | metanephric nephron tubule development (GO:0072234) | 3.97092804 |
| 15 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.94122712 |
| 16 | protein insertion into membrane (GO:0051205) | 3.89923258 |
| 17 | transmission of nerve impulse (GO:0019226) | 3.88437688 |
| 18 | cellular response to ATP (GO:0071318) | 3.86379857 |
| 19 | negative regulation of response to food (GO:0032096) | 3.78351281 |
| 20 | negative regulation of appetite (GO:0032099) | 3.78351281 |
| 21 | protein polyglutamylation (GO:0018095) | 3.78147744 |
| 22 | metanephric mesenchyme development (GO:0072075) | 3.75646068 |
| 23 | neuron cell-cell adhesion (GO:0007158) | 3.73839745 |
| 24 | nephron tubule development (GO:0072080) | 3.72996268 |
| 25 | chondrocyte proliferation (GO:0035988) | 3.71342592 |
| 26 | otic vesicle formation (GO:0030916) | 3.70422833 |
| 27 | layer formation in cerebral cortex (GO:0021819) | 3.69249918 |
| 28 | postsynaptic membrane organization (GO:0001941) | 3.57844034 |
| 29 | metanephric nephron epithelium development (GO:0072243) | 3.57671251 |
| 30 | gamma-aminobutyric acid transport (GO:0015812) | 3.57518293 |
| 31 | regulation of chromatin binding (GO:0035561) | 3.56308336 |
| 32 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.50246267 |
| 33 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.44860287 |
| 34 | metanephric epithelium development (GO:0072207) | 3.41414129 |
| 35 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.39355864 |
| 36 | glial cell proliferation (GO:0014009) | 3.39077053 |
| 37 | renal tubule development (GO:0061326) | 3.38314214 |
| 38 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.37682850 |
| 39 | kidney mesenchyme development (GO:0072074) | 3.37613167 |
| 40 | ovulation cycle (GO:0042698) | 3.37339207 |
| 41 | positive regulation of gastrulation (GO:2000543) | 3.36957546 |
| 42 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.36438075 |
| 43 | dendrite morphogenesis (GO:0048813) | 3.36120292 |
| 44 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.33652806 |
| 45 | lateral sprouting from an epithelium (GO:0060601) | 3.32944015 |
| 46 | lung morphogenesis (GO:0060425) | 3.30941316 |
| 47 | regulation of female gonad development (GO:2000194) | 3.28057169 |
| 48 | presynaptic membrane assembly (GO:0097105) | 3.23637547 |
| 49 | regulation of collateral sprouting (GO:0048670) | 3.23136568 |
| 50 | gastrulation with mouth forming second (GO:0001702) | 3.22919672 |
| 51 | positive regulation of fatty acid oxidation (GO:0046321) | 3.20487726 |
| 52 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.18309574 |
| 53 | axon extension (GO:0048675) | 3.17020600 |
| 54 | kidney morphogenesis (GO:0060993) | 3.10427408 |
| 55 | axon extension involved in axon guidance (GO:0048846) | 3.08794524 |
| 56 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.08794524 |
| 57 | negative regulation of astrocyte differentiation (GO:0048712) | 3.06612589 |
| 58 | head development (GO:0060322) | 3.05937561 |
| 59 | nephron epithelium development (GO:0072009) | 3.03826755 |
| 60 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.02189211 |
| 61 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.01009920 |
| 62 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.01009920 |
| 63 | regulation of DNA endoreduplication (GO:0032875) | 3.00605318 |
| 64 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.99349972 |
| 65 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.98614621 |
| 66 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.97612159 |
| 67 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.97612159 |
| 68 | NADH dehydrogenase complex assembly (GO:0010257) | 2.97612159 |
| 69 | limb bud formation (GO:0060174) | 2.97500016 |
| 70 | regulation of hippo signaling (GO:0035330) | 2.97450879 |
| 71 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.94662403 |
| 72 | nephron tubule formation (GO:0072079) | 2.93426652 |
| 73 | negative chemotaxis (GO:0050919) | 2.93403064 |
| 74 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.92739418 |
| 75 | retinal ganglion cell axon guidance (GO:0031290) | 2.92421997 |
| 76 | presynaptic membrane organization (GO:0097090) | 2.91987976 |
| 77 | collecting duct development (GO:0072044) | 2.91715714 |
| 78 | negative regulation of axon guidance (GO:1902668) | 2.91340292 |
| 79 | dendritic spine morphogenesis (GO:0060997) | 2.90837895 |
| 80 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.90230599 |
| 81 | protein localization to cilium (GO:0061512) | 2.90198952 |
| 82 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.89419049 |
| 83 | proximal/distal pattern formation (GO:0009954) | 2.88375757 |
| 84 | specification of organ identity (GO:0010092) | 2.88197369 |
| 85 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.87736355 |
| 86 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.87497243 |
| 87 | regulation of axon guidance (GO:1902667) | 2.86831269 |
| 88 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.86512096 |
| 89 | cranial nerve structural organization (GO:0021604) | 2.85686016 |
| 90 | cellular anion homeostasis (GO:0030002) | 2.84432867 |
| 91 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.84184597 |
| 92 | facial nerve structural organization (GO:0021612) | 2.83637381 |
| 93 | neuron projection extension (GO:1990138) | 2.83455767 |
| 94 | urogenital system development (GO:0001655) | 2.83432424 |
| 95 | cranial nerve morphogenesis (GO:0021602) | 2.83394674 |
| 96 | embryonic body morphogenesis (GO:0010172) | 2.82951058 |
| 97 | cerebral cortex neuron differentiation (GO:0021895) | 2.82374280 |
| 98 | lung-associated mesenchyme development (GO:0060484) | 2.78479056 |
| 99 | auditory receptor cell differentiation (GO:0042491) | 2.77964472 |
| 100 | cell migration in hindbrain (GO:0021535) | 2.76141357 |
| 101 | regulation of female receptivity (GO:0045924) | 2.76108070 |
| 102 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.75400490 |
| 103 | intraciliary transport (GO:0042073) | 2.75080157 |
| 104 | parturition (GO:0007567) | 2.73474665 |
| 105 | outer ear morphogenesis (GO:0042473) | 2.72328625 |
| 106 | notochord development (GO:0030903) | 2.72158472 |
| 107 | flavonoid metabolic process (GO:0009812) | 2.72100459 |
| 108 | tooth mineralization (GO:0034505) | 2.71412526 |
| 109 | positive regulation of synapse maturation (GO:0090129) | 2.71149526 |
| 110 | cochlea morphogenesis (GO:0090103) | 2.69284035 |
| 111 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.69014681 |
| 112 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.68890389 |
| 113 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.68690842 |
| 114 | positive regulation of metanephros development (GO:0072216) | 2.66669789 |
| 115 | neuromuscular synaptic transmission (GO:0007274) | 2.66625574 |
| 116 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.66200657 |
| 117 | mesonephros development (GO:0001823) | 2.65648593 |
| 118 | negative regulation of catenin import into nucleus (GO:0035414) | 2.65557005 |
| 119 | glomerulus development (GO:0032835) | 2.64303673 |
| 120 | kynurenine metabolic process (GO:0070189) | 2.63690940 |
| 121 | embryonic hindlimb morphogenesis (GO:0035116) | 2.63464183 |
| 122 | central nervous system neuron development (GO:0021954) | 2.63432108 |
| 123 | pituitary gland development (GO:0021983) | 2.63281566 |
| 124 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.63206112 |
| 125 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.62739212 |
| 126 | anatomical structure arrangement (GO:0048532) | 2.62214518 |
| 127 | hippocampus development (GO:0021766) | 2.61878928 |
| 128 | pharyngeal system development (GO:0060037) | 2.61372781 |
| 129 | multicellular organismal signaling (GO:0035637) | 2.61116906 |
| 130 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.60941761 |
| 131 | ganglion development (GO:0061548) | 2.60750550 |
| 132 | nonmotile primary cilium assembly (GO:0035058) | 2.60404784 |
| 133 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.60030925 |
| 134 | membrane depolarization during action potential (GO:0086010) | 2.59489467 |
| 135 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.59005310 |
| 136 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.58581550 |
| 137 | negative regulation of telomere maintenance (GO:0032205) | 2.58428485 |
| 138 | membrane repolarization during action potential (GO:0086011) | 2.57915853 |
| 139 | protein localization to synapse (GO:0035418) | 2.57704300 |
| 140 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.57294831 |
| 141 | ephrin receptor signaling pathway (GO:0048013) | 2.57073177 |
| 142 | forebrain neuron development (GO:0021884) | 2.56014293 |
| 143 | dorsal/ventral pattern formation (GO:0009953) | 2.55833583 |
| 144 | forebrain neuron differentiation (GO:0021879) | 2.55749471 |
| 145 | regulation of sequestering of triglyceride (GO:0010889) | 2.55289111 |
| 146 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.55111376 |
| 147 | regulation of action potential (GO:0098900) | 2.55083658 |
| 148 | negative regulation of microtubule polymerization (GO:0031115) | 2.54800869 |
| 149 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.54759474 |
| 150 | indole-containing compound catabolic process (GO:0042436) | 2.54439036 |
| 151 | indolalkylamine catabolic process (GO:0046218) | 2.54439036 |
| 152 | tryptophan catabolic process (GO:0006569) | 2.54439036 |
| 153 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.54405342 |
| 154 | detection of light stimulus involved in visual perception (GO:0050908) | 2.54405342 |
| 155 | motor neuron axon guidance (GO:0008045) | 2.54257597 |
| 156 | gonadal mesoderm development (GO:0007506) | 2.53262392 |
| 157 | cell differentiation in hindbrain (GO:0021533) | 2.53029205 |
| 158 | limb development (GO:0060173) | 2.52979100 |
| 159 | appendage development (GO:0048736) | 2.52979100 |
| 160 | negative regulation of embryonic development (GO:0045992) | 2.52482332 |
| 161 | regulation of telomerase activity (GO:0051972) | 2.51954189 |
| 162 | left/right axis specification (GO:0070986) | 2.51135837 |
| 163 | cell differentiation in spinal cord (GO:0021515) | 2.50458095 |
| 164 | regulation of transcription regulatory region DNA binding (GO:2000677) | 2.50341861 |
| 165 | positive regulation of glomerulus development (GO:0090193) | 2.50251272 |
| 166 | endoderm formation (GO:0001706) | 2.50120353 |
| 167 | negative regulation of cardiac muscle tissue development (GO:0055026) | 2.49201180 |
| 168 | spinal cord association neuron differentiation (GO:0021527) | 2.49034290 |
| 169 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.48462175 |
| 170 | regulation of synapse maturation (GO:0090128) | 2.46922956 |
| 171 | central nervous system neuron axonogenesis (GO:0021955) | 2.46831663 |
| 172 | regulation of response to food (GO:0032095) | 2.46406867 |
| 173 | hippo signaling (GO:0035329) | 2.44558678 |
| 174 | embryonic forelimb morphogenesis (GO:0035115) | 2.44533831 |
| 175 | body morphogenesis (GO:0010171) | 2.44489312 |
| 176 | negative regulation of anoikis (GO:2000811) | 2.41665650 |
| 177 | neuroblast proliferation (GO:0007405) | 2.40963354 |
| 178 | dermatan sulfate biosynthetic process (GO:0030208) | 2.39765419 |
| 179 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.39632021 |
| 180 | locomotory exploration behavior (GO:0035641) | 2.39485013 |
| 181 | negative regulation of axon extension (GO:0030517) | 2.39095680 |
| 182 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.37231688 |
| 183 | forelimb morphogenesis (GO:0035136) | 2.36232517 |
| 184 | vocalization behavior (GO:0071625) | 2.35873383 |
| 185 | atrial cardiac muscle cell action potential (GO:0086014) | 2.35540958 |
| 186 | negative regulation of smoothened signaling pathway (GO:0045879) | 2.34927475 |
| 187 | morphogenesis of an epithelial sheet (GO:0002011) | 2.34629893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.70206210 |
| 2 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 3.02103379 |
| 3 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 3.02103379 |
| 4 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.98592324 |
| 5 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.93108492 |
| 6 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.76909017 |
| 7 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.61335897 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.59939574 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.58709352 |
| 10 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55379789 |
| 11 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.54819022 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53928373 |
| 13 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.35292263 |
| 14 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.29491005 |
| 15 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.27338975 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.18293962 |
| 17 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.17931935 |
| 18 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.14280057 |
| 19 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.13666544 |
| 20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.13031776 |
| 21 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.08019844 |
| 22 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.05217896 |
| 23 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.94816405 |
| 24 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.92771859 |
| 25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.86430739 |
| 26 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.84776434 |
| 27 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.78836701 |
| 28 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.77931230 |
| 29 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.72172124 |
| 30 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.71036171 |
| 31 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.69949772 |
| 32 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.65875933 |
| 33 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.65235834 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.63235957 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.63121558 |
| 36 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.62324119 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.60194025 |
| 38 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.52685402 |
| 39 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.49497405 |
| 40 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.44963598 |
| 41 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.44028028 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42991269 |
| 43 | * HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.41251305 |
| 44 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.41236001 |
| 45 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.38720592 |
| 46 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37840720 |
| 47 | VDR_22108803_ChIP-Seq_LS180_Human | 1.37519825 |
| 48 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.37016309 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.35443313 |
| 50 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.33396960 |
| 51 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.32606514 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31592814 |
| 53 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.30614986 |
| 54 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.28161012 |
| 55 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.26578205 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25767600 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25579458 |
| 58 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.24615388 |
| 59 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.24146510 |
| 60 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.21481738 |
| 61 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.20577472 |
| 62 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.19673358 |
| 63 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19673358 |
| 64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19667481 |
| 65 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.19412537 |
| 66 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.19178211 |
| 67 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17733356 |
| 68 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.17141726 |
| 69 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.16474493 |
| 70 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16411383 |
| 71 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.16331893 |
| 72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.15666959 |
| 73 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15567555 |
| 74 | P300_19829295_ChIP-Seq_ESCs_Human | 1.15384347 |
| 75 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.14669668 |
| 76 | EWS_26573619_Chip-Seq_HEK293_Human | 1.13511812 |
| 77 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.13083994 |
| 78 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.09023219 |
| 79 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.08718618 |
| 80 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08630284 |
| 81 | * ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07571203 |
| 82 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.07277793 |
| 83 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06796853 |
| 84 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06513123 |
| 85 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06466252 |
| 86 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.06195944 |
| 87 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05604710 |
| 88 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.03815388 |
| 89 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.03631531 |
| 90 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01899260 |
| 91 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01207099 |
| 92 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.01012015 |
| 93 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.00659311 |
| 94 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99891732 |
| 95 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.99749165 |
| 96 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99015159 |
| 97 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.98998423 |
| 98 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.97776303 |
| 99 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.97333119 |
| 100 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.97248572 |
| 101 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.96404588 |
| 102 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96289535 |
| 103 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95616304 |
| 104 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.95407343 |
| 105 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95334016 |
| 106 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95005711 |
| 107 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.94894772 |
| 108 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.94346571 |
| 109 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.94026519 |
| 110 | AR_19668381_ChIP-Seq_PC3_Human | 0.93960654 |
| 111 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93920378 |
| 112 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93433180 |
| 113 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.93375079 |
| 114 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93373859 |
| 115 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92282527 |
| 116 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91312326 |
| 117 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91276560 |
| 118 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90747383 |
| 119 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89652812 |
| 120 | FUS_26573619_Chip-Seq_HEK293_Human | 0.89603800 |
| 121 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89534806 |
| 122 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.89326955 |
| 123 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88987272 |
| 124 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.88446351 |
| 125 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.87894262 |
| 126 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.87363509 |
| 127 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87326964 |
| 128 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87089214 |
| 129 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.86947845 |
| 130 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.85455289 |
| 131 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.85137406 |
| 132 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.85137406 |
| 133 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.84897819 |
| 134 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84577139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001984_abnormal_olfaction | 5.18090091 |
| 2 | MP0008789_abnormal_olfactory_epithelium | 4.07237225 |
| 3 | MP0005499_abnormal_olfactory_system | 3.47502853 |
| 4 | MP0005394_taste/olfaction_phenotype | 3.47502853 |
| 5 | MP0010030_abnormal_orbit_morphology | 2.78232829 |
| 6 | * MP0000778_abnormal_nervous_system | 2.52162134 |
| 7 | MP0003880_abnormal_central_pattern | 2.34467332 |
| 8 | MP0005377_hearing/vestibular/ear_phenot | 2.27363654 |
| 9 | MP0003878_abnormal_ear_physiology | 2.27363654 |
| 10 | MP0002653_abnormal_ependyma_morphology | 2.24821837 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.10252174 |
| 12 | MP0005623_abnormal_meninges_morphology | 2.08698037 |
| 13 | MP0002233_abnormal_nose_morphology | 2.08592251 |
| 14 | MP0000537_abnormal_urethra_morphology | 2.04842619 |
| 15 | MP0003787_abnormal_imprinting | 2.02587020 |
| 16 | MP0004145_abnormal_muscle_electrophysio | 2.00347909 |
| 17 | MP0004130_abnormal_muscle_cell | 1.98501454 |
| 18 | MP0008438_abnormal_cutaneous_collagen | 1.98019030 |
| 19 | MP0003646_muscle_fatigue | 1.96757732 |
| 20 | * MP0000049_abnormal_middle_ear | 1.96056639 |
| 21 | MP0000534_abnormal_ureter_morphology | 1.95923424 |
| 22 | MP0003942_abnormal_urinary_system | 1.95771431 |
| 23 | MP0009250_abnormal_appendicular_skeleto | 1.95004216 |
| 24 | MP0009379_abnormal_foot_pigmentation | 1.86511366 |
| 25 | MP0001440_abnormal_grooming_behavior | 1.84010673 |
| 26 | MP0009053_abnormal_anal_canal | 1.81476703 |
| 27 | MP0002249_abnormal_larynx_morphology | 1.80741834 |
| 28 | MP0002163_abnormal_gland_morphology | 1.75462729 |
| 29 | MP0004134_abnormal_chest_morphology | 1.74005612 |
| 30 | MP0002184_abnormal_innervation | 1.73068821 |
| 31 | * MP0002272_abnormal_nervous_system | 1.72708492 |
| 32 | MP0009745_abnormal_behavioral_response | 1.68528465 |
| 33 | MP0003385_abnormal_body_wall | 1.66160189 |
| 34 | MP0001958_emphysema | 1.63338653 |
| 35 | MP0005551_abnormal_eye_electrophysiolog | 1.55526169 |
| 36 | MP0004142_abnormal_muscle_tone | 1.54448707 |
| 37 | MP0005670_abnormal_white_adipose | 1.54318030 |
| 38 | MP0001968_abnormal_touch/_nociception | 1.54161305 |
| 39 | MP0003938_abnormal_ear_development | 1.52903927 |
| 40 | MP0000566_synostosis | 1.50635412 |
| 41 | MP0002733_abnormal_thermal_nociception | 1.50079532 |
| 42 | MP0003879_abnormal_hair_cell | 1.49489629 |
| 43 | MP0005423_abnormal_somatic_nervous | 1.46051295 |
| 44 | MP0002064_seizures | 1.43827393 |
| 45 | MP0006072_abnormal_retinal_apoptosis | 1.43442707 |
| 46 | MP0005389_reproductive_system_phenotype | 1.42990756 |
| 47 | MP0008872_abnormal_physiological_respon | 1.42167397 |
| 48 | MP0002735_abnormal_chemical_nociception | 1.41044946 |
| 49 | MP0003755_abnormal_palate_morphology | 1.40004240 |
| 50 | MP0002932_abnormal_joint_morphology | 1.39415357 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.38942924 |
| 52 | MP0001970_abnormal_pain_threshold | 1.38808624 |
| 53 | MP0002282_abnormal_trachea_morphology | 1.37709322 |
| 54 | * MP0001485_abnormal_pinna_reflex | 1.37170566 |
| 55 | MP0003123_paternal_imprinting | 1.37129462 |
| 56 | * MP0000026_abnormal_inner_ear | 1.37116588 |
| 57 | MP0003941_abnormal_skin_development | 1.37092901 |
| 58 | MP0003937_abnormal_limbs/digits/tail_de | 1.36888059 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.36863157 |
| 60 | * MP0003861_abnormal_nervous_system | 1.35431664 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.34670943 |
| 62 | MP0004885_abnormal_endolymph | 1.33613481 |
| 63 | MP0005503_abnormal_tendon_morphology | 1.33262706 |
| 64 | MP0002896_abnormal_bone_mineralization | 1.31998333 |
| 65 | MP0003890_abnormal_embryonic-extraembry | 1.28658907 |
| 66 | * MP0002116_abnormal_craniofacial_bone | 1.26969922 |
| 67 | MP0005248_abnormal_Harderian_gland | 1.26751101 |
| 68 | MP0003121_genomic_imprinting | 1.24705632 |
| 69 | MP0004270_analgesia | 1.24654939 |
| 70 | MP0009046_muscle_twitch | 1.23077358 |
| 71 | MP0003122_maternal_imprinting | 1.22610117 |
| 72 | MP0003283_abnormal_digestive_organ | 1.22149872 |
| 73 | MP0004858_abnormal_nervous_system | 1.21998903 |
| 74 | MP0002557_abnormal_social/conspecific_i | 1.21817139 |
| 75 | MP0002928_abnormal_bile_duct | 1.21338074 |
| 76 | MP0005187_abnormal_penis_morphology | 1.21179527 |
| 77 | MP0005257_abnormal_intraocular_pressure | 1.20986204 |
| 78 | MP0000538_abnormal_urinary_bladder | 1.20861103 |
| 79 | * MP0002752_abnormal_somatic_nervous | 1.16613712 |
| 80 | MP0002102_abnormal_ear_morphology | 1.16028715 |
| 81 | MP0001293_anophthalmia | 1.13915891 |
| 82 | * MP0000631_abnormal_neuroendocrine_gland | 1.13742985 |
| 83 | MP0003315_abnormal_perineum_morphology | 1.13057030 |
| 84 | * MP0005195_abnormal_posterior_eye | 1.12623494 |
| 85 | MP0005508_abnormal_skeleton_morphology | 1.12429397 |
| 86 | MP0005646_abnormal_pituitary_gland | 1.12286779 |
| 87 | * MP0002152_abnormal_brain_morphology | 1.11907568 |
| 88 | MP0002638_abnormal_pupillary_reflex | 1.11737696 |
| 89 | MP0000678_abnormal_parathyroid_gland | 1.10874856 |
| 90 | MP0000428_abnormal_craniofacial_morphol | 1.10304077 |
| 91 | MP0002063_abnormal_learning/memory/cond | 1.10251418 |
| 92 | MP0001299_abnormal_eye_distance/ | 1.09499682 |
| 93 | MP0002160_abnormal_reproductive_system | 1.09469377 |
| 94 | MP0005367_renal/urinary_system_phenotyp | 1.08486991 |
| 95 | MP0000516_abnormal_urinary_system | 1.08486991 |
| 96 | MP0003635_abnormal_synaptic_transmissio | 1.07796068 |
| 97 | MP0002734_abnormal_mechanical_nocicepti | 1.07762025 |
| 98 | * MP0002882_abnormal_neuron_morphology | 1.06760271 |
| 99 | MP0006276_abnormal_autonomic_nervous | 1.05283961 |
| 100 | MP0002089_abnormal_postnatal_growth/wei | 1.05270467 |
| 101 | MP0004742_abnormal_vestibular_system | 1.04522931 |
| 102 | MP0001286_abnormal_eye_development | 1.04291679 |
| 103 | MP0002254_reproductive_system_inflammat | 1.03620814 |
| 104 | MP0005645_abnormal_hypothalamus_physiol | 1.02354552 |
| 105 | MP0001502_abnormal_circadian_rhythm | 1.02242983 |
| 106 | MP0002067_abnormal_sensory_capabilities | 1.00283664 |
| 107 | MP0003115_abnormal_respiratory_system | 0.99797151 |
| 108 | MP0002837_dystrophic_cardiac_calcinosis | 0.99037384 |
| 109 | MP0001486_abnormal_startle_reflex | 0.98661990 |
| 110 | MP0009384_cardiac_valve_regurgitation | 0.98617060 |
| 111 | MP0002092_abnormal_eye_morphology | 0.96720168 |
| 112 | MP0002115_abnormal_skeleton_extremities | 0.96500419 |
| 113 | MP0003935_abnormal_craniofacial_develop | 0.96127867 |
| 114 | MP0000163_abnormal_cartilage_morphology | 0.94523246 |
| 115 | MP0003119_abnormal_digestive_system | 0.92985367 |
| 116 | MP0003195_calcinosis | 0.92875611 |
| 117 | MP0002234_abnormal_pharynx_morphology | 0.91614275 |
| 118 | MP0000432_abnormal_head_morphology | 0.91192976 |
| 119 | MP0000762_abnormal_tongue_morphology | 0.90353311 |
| 120 | MP0002736_abnormal_nociception_after | 0.90343300 |
| 121 | MP0001346_abnormal_lacrimal_gland | 0.90177474 |
| 122 | MP0004272_abnormal_basement_membrane | 0.89991727 |
| 123 | MP0001905_abnormal_dopamine_level | 0.88712083 |
| 124 | MP0002177_abnormal_outer_ear | 0.88645070 |
| 125 | MP0002109_abnormal_limb_morphology | 0.86997671 |
| 126 | MP0005253_abnormal_eye_physiology | 0.86708726 |
| 127 | MP0005084_abnormal_gallbladder_morpholo | 0.86465206 |
| 128 | MP0002697_abnormal_eye_size | 0.86440972 |
| 129 | MP0002114_abnormal_axial_skeleton | 0.85463372 |
| 130 | MP0005275_abnormal_skin_tensile | 0.85284262 |
| 131 | MP0006292_abnormal_olfactory_placode | 0.85263307 |
| 132 | MP0009780_abnormal_chondrocyte_physiolo | 0.84395595 |
| 133 | MP0004133_heterotaxia | 0.84183614 |
| 134 | * MP0002081_perinatal_lethality | 0.84059060 |
| 135 | MP0002751_abnormal_autonomic_nervous | 0.83522828 |
| 136 | MP0005379_endocrine/exocrine_gland_phen | 0.83520452 |
| 137 | MP0002938_white_spotting | 0.82942217 |
| 138 | MP0001177_atelectasis | 0.81492806 |
| 139 | * MP0001963_abnormal_hearing_physiology | 0.80320291 |
| 140 | MP0002111_abnormal_tail_morphology | 0.79475740 |
| 141 | MP0002572_abnormal_emotion/affect_behav | 0.78938819 |
| 142 | MP0001340_abnormal_eyelid_morphology | 0.76843631 |
| 143 | MP0000955_abnormal_spinal_cord | 0.75803962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Genetic anticipation (HP:0003743) | 4.58285843 |
| 2 | Progressive cerebellar ataxia (HP:0002073) | 3.82674191 |
| 3 | Pendular nystagmus (HP:0012043) | 3.79101605 |
| 4 | True hermaphroditism (HP:0010459) | 3.74562088 |
| 5 | Pancreatic fibrosis (HP:0100732) | 3.74335431 |
| 6 | Pancreatic cysts (HP:0001737) | 3.66261028 |
| 7 | Abnormality of dentin (HP:0010299) | 3.66191756 |
| 8 | Premature rupture of membranes (HP:0001788) | 3.39739182 |
| 9 | Short 1st metacarpal (HP:0010034) | 3.33457988 |
| 10 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.33457988 |
| 11 | Morphological abnormality of the middle ear (HP:0008609) | 3.26313571 |
| 12 | Agitation (HP:0000713) | 3.22025537 |
| 13 | Stenosis of the external auditory canal (HP:0000402) | 3.06827539 |
| 14 | Shallow orbits (HP:0000586) | 2.95343434 |
| 15 | Increased circulating renin level (HP:0000848) | 2.93175975 |
| 16 | Abnormality of the 1st metacarpal (HP:0010009) | 2.90490290 |
| 17 | Abolished electroretinogram (ERG) (HP:0000550) | 2.90029917 |
| 18 | Metabolic alkalosis (HP:0200114) | 2.82500142 |
| 19 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.81152420 |
| 20 | Asplenia (HP:0001746) | 2.78308436 |
| 21 | Neonatal short-limb short stature (HP:0008921) | 2.76997036 |
| 22 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.76542907 |
| 23 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.72573735 |
| 24 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.72013033 |
| 25 | Abnormality of DNA repair (HP:0003254) | 2.70523402 |
| 26 | Abnormality of the nasal septum (HP:0000419) | 2.69497478 |
| 27 | Cystic liver disease (HP:0006706) | 2.66990521 |
| 28 | Bell-shaped thorax (HP:0001591) | 2.66281328 |
| 29 | Septo-optic dysplasia (HP:0100842) | 2.63262692 |
| 30 | Short 4th metacarpal (HP:0010044) | 2.62848981 |
| 31 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.62848981 |
| 32 | Aplasia of the phalanges of the hand (HP:0009802) | 2.58000276 |
| 33 | Aplasia involving bones of the extremities (HP:0009825) | 2.58000276 |
| 34 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.58000276 |
| 35 | Increased corneal curvature (HP:0100692) | 2.56852538 |
| 36 | Keratoconus (HP:0000563) | 2.56852538 |
| 37 | Severe visual impairment (HP:0001141) | 2.55372838 |
| 38 | Type II lissencephaly (HP:0007260) | 2.54041911 |
| 39 | Ectopic kidney (HP:0000086) | 2.53544470 |
| 40 | Gait imbalance (HP:0002141) | 2.53314833 |
| 41 | Short phalanx of the thumb (HP:0009660) | 2.52006798 |
| 42 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.50303136 |
| 43 | Protrusio acetabuli (HP:0003179) | 2.48279438 |
| 44 | Medial flaring of the eyebrow (HP:0010747) | 2.48157973 |
| 45 | Short nail (HP:0001799) | 2.46247514 |
| 46 | Short femoral neck (HP:0100864) | 2.43074300 |
| 47 | Anomalous pulmonary venous return (HP:0010772) | 2.41119377 |
| 48 | Bicornuate uterus (HP:0000813) | 2.40007883 |
| 49 | Aortic dissection (HP:0002647) | 2.37380246 |
| 50 | Short hallux (HP:0010109) | 2.36721798 |
| 51 | Synostosis of carpal bones (HP:0005048) | 2.36642327 |
| 52 | Confusion (HP:0001289) | 2.36142039 |
| 53 | Absent thumb (HP:0009777) | 2.34150753 |
| 54 | Absent/shortened dynein arms (HP:0200106) | 2.33047537 |
| 55 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.33047537 |
| 56 | Sclerocornea (HP:0000647) | 2.31627605 |
| 57 | Decreased central vision (HP:0007663) | 2.30849295 |
| 58 | Anencephaly (HP:0002323) | 2.29125707 |
| 59 | Renal hypoplasia (HP:0000089) | 2.28529568 |
| 60 | Nephrogenic diabetes insipidus (HP:0009806) | 2.25357839 |
| 61 | Bifid tongue (HP:0010297) | 2.25163002 |
| 62 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.23788980 |
| 63 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.23755743 |
| 64 | Congenital primary aphakia (HP:0007707) | 2.22778744 |
| 65 | Hypoplasia of the ulna (HP:0003022) | 2.22294020 |
| 66 | Congenital stationary night blindness (HP:0007642) | 2.21743402 |
| 67 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.21385636 |
| 68 | Vaginal atresia (HP:0000148) | 2.19958761 |
| 69 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.19132602 |
| 70 | Furrowed tongue (HP:0000221) | 2.18411413 |
| 71 | Genital tract atresia (HP:0001827) | 2.17598092 |
| 72 | Cutaneous finger syndactyly (HP:0010554) | 2.16575792 |
| 73 | Tubular atrophy (HP:0000092) | 2.15387076 |
| 74 | Megalencephaly (HP:0001355) | 2.14027743 |
| 75 | Anosmia (HP:0000458) | 2.14026428 |
| 76 | Synostosis involving the elbow (HP:0003938) | 2.12508779 |
| 77 | Humeroradial synostosis (HP:0003041) | 2.12508779 |
| 78 | Abnormality of the pulmonary veins (HP:0011718) | 2.08917495 |
| 79 | Chronic hepatic failure (HP:0100626) | 2.08077574 |
| 80 | Diplopia (HP:0000651) | 2.07916703 |
| 81 | Abnormality of binocular vision (HP:0011514) | 2.07916703 |
| 82 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.06724107 |
| 83 | Polyuria (HP:0000103) | 2.06375909 |
| 84 | Abnormal number of incisors (HP:0011064) | 2.05673589 |
| 85 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.04485352 |
| 86 | Abnormality of molar morphology (HP:0011070) | 2.02631737 |
| 87 | Abnormality of molar (HP:0011077) | 2.02631737 |
| 88 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.02555331 |
| 89 | Postaxial hand polydactyly (HP:0001162) | 2.02027042 |
| 90 | Coronal craniosynostosis (HP:0004440) | 2.00967681 |
| 91 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.00506986 |
| 92 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.00299472 |
| 93 | Fibular aplasia (HP:0002990) | 1.98447533 |
| 94 | Hyperactive renin-angiotensin system (HP:0000841) | 1.98331989 |
| 95 | Myokymia (HP:0002411) | 1.98315168 |
| 96 | Omphalocele (HP:0001539) | 1.98007692 |
| 97 | Congenital sensorineural hearing impairment (HP:0008527) | 1.97865095 |
| 98 | Abnormality of midbrain morphology (HP:0002418) | 1.97505780 |
| 99 | Molar tooth sign on MRI (HP:0002419) | 1.97505780 |
| 100 | Postaxial foot polydactyly (HP:0001830) | 1.97295463 |
| 101 | Action tremor (HP:0002345) | 1.97068934 |
| 102 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.96445224 |
| 103 | Visual hallucinations (HP:0002367) | 1.96357644 |
| 104 | Arterial tortuosity (HP:0005116) | 1.96282865 |
| 105 | Hypokalemic alkalosis (HP:0001949) | 1.95919753 |
| 106 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.95851300 |
| 107 | Abnormality of the renal medulla (HP:0100957) | 1.95023238 |
| 108 | Natal tooth (HP:0000695) | 1.93996790 |
| 109 | Abnormality of the renal collecting system (HP:0004742) | 1.93981117 |
| 110 | Retinal dysplasia (HP:0007973) | 1.92146581 |
| 111 | Reticulocytopenia (HP:0001896) | 1.91982571 |
| 112 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.91884319 |
| 113 | Abnormality of the 4th metacarpal (HP:0010012) | 1.90396657 |
| 114 | Male pseudohermaphroditism (HP:0000037) | 1.89075186 |
| 115 | Hemiplegia (HP:0002301) | 1.88838086 |
| 116 | Cerebellar dysplasia (HP:0007033) | 1.88352666 |
| 117 | Cutaneous syndactyly (HP:0012725) | 1.88110850 |
| 118 | Hypomagnesemia (HP:0002917) | 1.87249657 |
| 119 | Soft skin (HP:0000977) | 1.86822880 |
| 120 | Vascular tortuosity (HP:0004948) | 1.86622062 |
| 121 | Carpal bone hypoplasia (HP:0001498) | 1.86036782 |
| 122 | Anterior segment dysgenesis (HP:0007700) | 1.86027535 |
| 123 | Abnormality of cochlea (HP:0000375) | 1.85767867 |
| 124 | Choanal stenosis (HP:0000452) | 1.85212239 |
| 125 | Methylmalonic acidemia (HP:0002912) | 1.84895508 |
| 126 | Congenital hepatic fibrosis (HP:0002612) | 1.84596430 |
| 127 | Rib fusion (HP:0000902) | 1.83678567 |
| 128 | Abnormal urine output (HP:0012590) | 1.83197708 |
| 129 | Pelvic girdle muscle weakness (HP:0003749) | 1.82294582 |
| 130 | Wrist flexion contracture (HP:0001239) | 1.82243964 |
| 131 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.82118724 |
| 132 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.82118724 |
| 133 | Taurodontia (HP:0000679) | 1.81956117 |
| 134 | Abnormality of permanent molar morphology (HP:0011071) | 1.81956117 |
| 135 | Abnormality of the dental root (HP:0006486) | 1.81956117 |
| 136 | Hyperaldosteronism (HP:0000859) | 1.80917176 |
| 137 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.80338911 |
| 138 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.79855281 |
| 139 | Abnormality of renal excretion (HP:0011036) | 1.79733464 |
| 140 | Focal seizures (HP:0007359) | 1.79370634 |
| 141 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.78566991 |
| 142 | Broad metatarsal (HP:0001783) | 1.77397172 |
| 143 | Small hand (HP:0200055) | 1.77262576 |
| 144 | Fibular hypoplasia (HP:0003038) | 1.76889160 |
| 145 | Hydroureter (HP:0000072) | 1.76392406 |
| 146 | Advanced eruption of teeth (HP:0006288) | 1.75795956 |
| 147 | Diastasis recti (HP:0001540) | 1.75716274 |
| 148 | Nephronophthisis (HP:0000090) | 1.75268307 |
| 149 | Hepatoblastoma (HP:0002884) | 1.74962863 |
| 150 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.74859363 |
| 151 | Gaze-evoked nystagmus (HP:0000640) | 1.74858951 |
| 152 | Adrenal hypoplasia (HP:0000835) | 1.74386393 |
| 153 | Broad ribs (HP:0000885) | 1.73913848 |
| 154 | Truncal obesity (HP:0001956) | 1.73886967 |
| 155 | Abnormality of the pubic bones (HP:0003172) | 1.73773136 |
| 156 | Abnormality of renin-angiotensin system (HP:0000847) | 1.73596583 |
| 157 | Buphthalmos (HP:0000557) | 1.71678284 |
| 158 | Abnormality of macular pigmentation (HP:0008002) | 1.71221578 |
| 159 | Turricephaly (HP:0000262) | 1.71105394 |
| 160 | Abnormal drinking behavior (HP:0030082) | 1.70385529 |
| 161 | Polydipsia (HP:0001959) | 1.70385529 |
| 162 | Shawl scrotum (HP:0000049) | 1.69843671 |
| 163 | Aortic aneurysm (HP:0004942) | 1.69293815 |
| 164 | Intellectual disability, moderate (HP:0002342) | 1.68883624 |
| 165 | Chorioretinal atrophy (HP:0000533) | 1.68237795 |
| 166 | Abnormality of the dental pulp (HP:0006479) | 1.66820234 |
| 167 | Complete atrioventricular canal defect (HP:0001674) | 1.65870431 |
| 168 | Abnormality of chloride homeostasis (HP:0011422) | 1.64576316 |
| 169 | Broad distal phalanx of finger (HP:0009836) | 1.64467639 |
| 170 | Midline defect of the nose (HP:0004122) | 1.64444279 |
| 171 | Lymphangioma (HP:0100764) | 1.64279670 |
| 172 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.64260657 |
| 173 | Stage 5 chronic kidney disease (HP:0003774) | 1.62800287 |
| 174 | Mixed hearing impairment (HP:0000410) | 1.62749825 |
| 175 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.61286517 |
| 176 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.61286517 |
| 177 | Abnormality of the antihelix (HP:0009738) | 1.60978954 |
| 178 | Abnormality of magnesium homeostasis (HP:0004921) | 1.60396282 |
| 179 | Atrioventricular canal defect (HP:0006695) | 1.60357619 |
| 180 | Bronchomalacia (HP:0002780) | 1.59058774 |
| 181 | Down-sloping shoulders (HP:0200021) | 1.57141933 |
| 182 | Microglossia (HP:0000171) | 1.56559209 |
| 183 | Supranuclear gaze palsy (HP:0000605) | 1.56315121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERBB3 | 3.63018753 |
| 2 | GRK1 | 3.29210157 |
| 3 | DDR2 | 3.20368233 |
| 4 | ADRBK2 | 3.08319824 |
| 5 | EPHB2 | 2.96497106 |
| 6 | FRK | 2.82524127 |
| 7 | MARK1 | 2.80355123 |
| 8 | SIK2 | 2.64386692 |
| 9 | EPHA4 | 2.50856599 |
| 10 | PHKG1 | 2.43863656 |
| 11 | PHKG2 | 2.43863656 |
| 12 | PINK1 | 2.29778096 |
| 13 | WNK3 | 2.27728616 |
| 14 | NTRK2 | 2.20596933 |
| 15 | MAPK13 | 2.13915294 |
| 16 | STK38L | 2.09575970 |
| 17 | TRIB3 | 2.05985987 |
| 18 | PAK3 | 2.02801944 |
| 19 | WNK4 | 2.01505691 |
| 20 | TLK1 | 1.97239766 |
| 21 | PLK2 | 1.95458907 |
| 22 | LATS2 | 1.82522980 |
| 23 | STK16 | 1.77118229 |
| 24 | NUAK1 | 1.70683073 |
| 25 | PRKD3 | 1.59275867 |
| 26 | OXSR1 | 1.54530936 |
| 27 | TAF1 | 1.52814663 |
| 28 | BMPR1B | 1.46202632 |
| 29 | CASK | 1.45676054 |
| 30 | DYRK1B | 1.45422620 |
| 31 | KSR1 | 1.43696569 |
| 32 | LMTK2 | 1.43502899 |
| 33 | PNCK | 1.42981266 |
| 34 | LATS1 | 1.39451835 |
| 35 | ZAK | 1.38022573 |
| 36 | MINK1 | 1.36036111 |
| 37 | DYRK2 | 1.35789657 |
| 38 | STK38 | 1.32212326 |
| 39 | CDK19 | 1.30444144 |
| 40 | MAP3K9 | 1.28354692 |
| 41 | MAP4K2 | 1.26240013 |
| 42 | SRPK1 | 1.25643518 |
| 43 | GRK7 | 1.21190575 |
| 44 | DYRK3 | 1.18339724 |
| 45 | SGK223 | 1.16344174 |
| 46 | SGK494 | 1.16344174 |
| 47 | TNIK | 1.13221945 |
| 48 | MKNK1 | 1.12637983 |
| 49 | PASK | 1.12590954 |
| 50 | PAK6 | 1.11072594 |
| 51 | DYRK1A | 1.10280924 |
| 52 | TYRO3 | 1.09164245 |
| 53 | INSRR | 1.08990794 |
| 54 | CDC7 | 1.08138367 |
| 55 | STK11 | 1.06350557 |
| 56 | PRKCH | 1.05819021 |
| 57 | EPHA3 | 1.05100525 |
| 58 | AKT3 | 1.03260545 |
| 59 | NTRK3 | 1.02799319 |
| 60 | CAMK1G | 1.01427895 |
| 61 | PDGFRA | 1.00537731 |
| 62 | SIK1 | 0.99195968 |
| 63 | TIE1 | 0.99023990 |
| 64 | CDK9 | 0.98378092 |
| 65 | CSNK1A1L | 0.97410967 |
| 66 | GRK5 | 0.95591879 |
| 67 | DAPK2 | 0.95491129 |
| 68 | NEK1 | 0.95391724 |
| 69 | WNK1 | 0.95244538 |
| 70 | FER | 0.94367498 |
| 71 | CAMK2B | 0.94364880 |
| 72 | BMPR2 | 0.93788948 |
| 73 | RPS6KA6 | 0.92842431 |
| 74 | CAMK1 | 0.92424680 |
| 75 | PKN1 | 0.91313227 |
| 76 | ADRBK1 | 0.91185940 |
| 77 | TTN | 0.90823446 |
| 78 | PTK2B | 0.90347406 |
| 79 | MAP3K4 | 0.89837537 |
| 80 | CSNK1G1 | 0.89668434 |
| 81 | AURKA | 0.88336624 |
| 82 | TAOK3 | 0.87871456 |
| 83 | STK39 | 0.82630302 |
| 84 | ROCK1 | 0.82404332 |
| 85 | ICK | 0.82154041 |
| 86 | ERBB2 | 0.81562824 |
| 87 | SGK2 | 0.80794701 |
| 88 | CAMKK1 | 0.80752968 |
| 89 | MAP2K7 | 0.80028141 |
| 90 | ROCK2 | 0.79953772 |
| 91 | NEK2 | 0.79532012 |
| 92 | PIK3CA | 0.76594718 |
| 93 | MKNK2 | 0.76132967 |
| 94 | CAMK4 | 0.75917004 |
| 95 | CAMKK2 | 0.74895624 |
| 96 | CSNK1G2 | 0.72484033 |
| 97 | PRKAA1 | 0.71113264 |
| 98 | PRKCG | 0.70622072 |
| 99 | PRKACA | 0.70510355 |
| 100 | MARK2 | 0.70489901 |
| 101 | RPS6KL1 | 0.69156384 |
| 102 | RPS6KC1 | 0.69156384 |
| 103 | CSNK1A1 | 0.68270834 |
| 104 | CAMK1D | 0.67992156 |
| 105 | FGR | 0.66923930 |
| 106 | ABL2 | 0.66692264 |
| 107 | PRKCE | 0.65392620 |
| 108 | CSNK1G3 | 0.64850687 |
| 109 | CDK5 | 0.64192660 |
| 110 | PRKCZ | 0.63472391 |
| 111 | UHMK1 | 0.61624028 |
| 112 | SGK1 | 0.59186057 |
| 113 | RIPK1 | 0.59170184 |
| 114 | PAK2 | 0.58706423 |
| 115 | PRKD2 | 0.58035242 |
| 116 | MAPK15 | 0.56668293 |
| 117 | MAPKAPK5 | 0.54888059 |
| 118 | FGFR1 | 0.54513301 |
| 119 | NTRK1 | 0.54420021 |
| 120 | FGFR2 | 0.54396689 |
| 121 | SGK3 | 0.52710232 |
| 122 | MAP2K4 | 0.52656749 |
| 123 | CDK14 | 0.50732545 |
| 124 | MAP3K10 | 0.50248936 |
| 125 | VRK1 | 0.50202717 |
| 126 | LIMK1 | 0.50159715 |
| 127 | RPS6KA5 | 0.49250537 |
| 128 | ILK | 0.49092414 |
| 129 | EIF2AK2 | 0.48941177 |
| 130 | CAMK2D | 0.48676713 |
| 131 | EEF2K | 0.47079955 |
| 132 | DAPK3 | 0.46876440 |
| 133 | MARK3 | 0.46505093 |
| 134 | RPS6KA2 | 0.45999963 |
| 135 | CAMK2A | 0.44814953 |
| 136 | ACVR1B | 0.44011815 |
| 137 | CDK18 | 0.42434617 |
| 138 | PTK2 | 0.41297443 |
| 139 | CDK15 | 0.41211971 |
| 140 | CDC42BPA | 0.41068962 |
| 141 | CAMK2G | 0.40973171 |
| 142 | PLK4 | 0.40479709 |
| 143 | PRKCI | 0.39170656 |
| 144 | DMPK | 0.37571312 |
| 145 | PAK4 | 0.36190569 |
| 146 | AKT2 | 0.34332632 |
| 147 | GSK3A | 0.33446549 |
| 148 | CDK11A | 0.32858750 |
| 149 | PTK6 | 0.32510850 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 5.40832061 |
| 2 | Axon guidance_Homo sapiens_hsa04360 | 2.38914777 |
| 3 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.22488495 |
| 4 | Basal cell carcinoma_Homo sapiens_hsa05217 | 2.13061570 |
| 5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.12717283 |
| 6 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.11162374 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.04250034 |
| 8 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.79319306 |
| 9 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.73980094 |
| 10 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.70867122 |
| 11 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.70833120 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.69711598 |
| 13 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.69491641 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.67505693 |
| 15 | Melanogenesis_Homo sapiens_hsa04916 | 1.66689569 |
| 16 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.61799864 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.51810415 |
| 18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.47875981 |
| 19 | Nicotine addiction_Homo sapiens_hsa05033 | 1.47689979 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.47523801 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.46385397 |
| 22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.44889810 |
| 23 | Ribosome_Homo sapiens_hsa03010 | 1.44682821 |
| 24 | Phototransduction_Homo sapiens_hsa04744 | 1.43249147 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.42055204 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.40233424 |
| 27 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.38270920 |
| 28 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.37458644 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.32037296 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.31605440 |
| 31 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.31221227 |
| 32 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.30975954 |
| 33 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.28407336 |
| 34 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.27982057 |
| 35 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.26837235 |
| 36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.23804558 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.21762184 |
| 38 | Insulin secretion_Homo sapiens_hsa04911 | 1.21417304 |
| 39 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.19327146 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.18811347 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.18204649 |
| 42 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.17278883 |
| 43 | Morphine addiction_Homo sapiens_hsa05032 | 1.17105543 |
| 44 | Gap junction_Homo sapiens_hsa04540 | 1.16695904 |
| 45 | GABAergic synapse_Homo sapiens_hsa04727 | 1.16521651 |
| 46 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.16347952 |
| 47 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.16319210 |
| 48 | Salivary secretion_Homo sapiens_hsa04970 | 1.16047600 |
| 49 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.15305307 |
| 50 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.14517350 |
| 51 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.11480803 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.11459746 |
| 53 | Parkinsons disease_Homo sapiens_hsa05012 | 1.10307241 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.09128999 |
| 55 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.08755429 |
| 56 | Homologous recombination_Homo sapiens_hsa03440 | 1.08202040 |
| 57 | Alzheimers disease_Homo sapiens_hsa05010 | 1.07597835 |
| 58 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.07065288 |
| 59 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.06760227 |
| 60 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.06312648 |
| 61 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.05939836 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04935767 |
| 63 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.02212105 |
| 64 | Long-term potentiation_Homo sapiens_hsa04720 | 1.01638831 |
| 65 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.00015042 |
| 66 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.98897086 |
| 67 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97216887 |
| 68 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.96777366 |
| 69 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.96350310 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.95238986 |
| 71 | Cocaine addiction_Homo sapiens_hsa05030 | 0.94900951 |
| 72 | Tight junction_Homo sapiens_hsa04530 | 0.94354995 |
| 73 | Focal adhesion_Homo sapiens_hsa04510 | 0.94092346 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92562290 |
| 75 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.91782954 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.91623751 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.90633624 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.90283455 |
| 79 | Adherens junction_Homo sapiens_hsa04520 | 0.90248833 |
| 80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.90221894 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88955257 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87192416 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.85918364 |
| 84 | Colorectal cancer_Homo sapiens_hsa05210 | 0.85644597 |
| 85 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.85530553 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.84553706 |
| 87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84206019 |
| 88 | Melanoma_Homo sapiens_hsa05218 | 0.84108848 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.83442515 |
| 90 | Huntingtons disease_Homo sapiens_hsa05016 | 0.83148121 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.83060381 |
| 92 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.82562458 |
| 93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82441387 |
| 94 | Long-term depression_Homo sapiens_hsa04730 | 0.81187346 |
| 95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.80423489 |
| 96 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.80331412 |
| 97 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.79713668 |
| 98 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.79526706 |
| 99 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79263979 |
| 100 | Bile secretion_Homo sapiens_hsa04976 | 0.77425975 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76943784 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.75437502 |
| 103 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74623661 |
| 104 | Sulfur relay system_Homo sapiens_hsa04122 | 0.74576980 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.73829729 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.73765935 |
| 107 | Basal transcription factors_Homo sapiens_hsa03022 | 0.72719082 |
| 108 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.72353040 |
| 109 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71918957 |
| 110 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71245762 |
| 111 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70606892 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70217623 |
| 113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69429064 |
| 114 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69251631 |
| 115 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.67449978 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64510723 |
| 117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63531672 |
| 118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62988120 |
| 119 | Renin secretion_Homo sapiens_hsa04924 | 0.62849250 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.60453378 |
| 121 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.59745625 |
| 122 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59477155 |
| 123 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58037393 |
| 124 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.58036282 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57359079 |
| 126 | Alcoholism_Homo sapiens_hsa05034 | 0.57174370 |
| 127 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56947046 |
| 128 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55656193 |
| 129 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.53779282 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53401073 |
| 131 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53288084 |
| 132 | Mineral absorption_Homo sapiens_hsa04978 | 0.52033037 |
| 133 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51590756 |
| 134 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49650972 |
| 135 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48369034 |
| 136 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.48338658 |
| 137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47893083 |
| 138 | Amoebiasis_Homo sapiens_hsa05146 | 0.47406936 |
| 139 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45803804 |
| 140 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45786801 |
| 141 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45230073 |
| 142 | RNA degradation_Homo sapiens_hsa03018 | 0.40290322 |

